Edition:
United Kingdom

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

2.58USD
21 Sep 2018
Change (% chg)

$0.12 (+4.88%)
Prev Close
$2.46
Open
$2.46
Day's High
$2.60
Day's Low
$2.44
Volume
101,117
Avg. Vol
93,596
52-wk High
$8.61
52-wk Low
$1.41

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.84 -0.430
Mar '18 0.94 -0.320
FY 2017 Dec '17 1.62 -0.507
Sep '17 1.55 -0.556
Jun '17 1.15 -0.677
Mar '17 1.02 -0.603
FY 2016 Dec '16 4.06 -0.376
Sep '16 1.72 -0.537
Jun '16 1.45 -0.473
Mar '16 1.16 -0.870
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 1.13 1.40 0.85 --
Quarter Ending Dec-18 2 1.13 1.40 0.86 --
Year Ending Dec-18 2 4.04 4.59 3.50 1.00
Year Ending Dec-19 2 4.17 4.81 3.53 0.50
Earnings (per share)
Quarter Ending Sep-18 2 -0.43 -0.40 -0.45 --
Quarter Ending Dec-18 2 -0.38 -0.29 -0.47 --
Year Ending Dec-18 2 -1.56 -1.44 -1.68 -2.62
Year Ending Dec-19 2 -1.47 -1.13 -1.81 -2.81
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 6.98 114.98 5.74
Price to Book (MRQ) 1.08 15.51 5.00
Price to Tangible Book (MRQ) 1.08 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 74.37 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -20.95 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago 57.47 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -43.17 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago 2.39 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 5.65 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 0.00 37.09 16.85
Interest Coverage (TTM) -177.45 -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -660.33 -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -664.11 -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -657.71 -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -657.71 -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 111,873 23,229,030 860,305,024
Net Income/Employee (TTM) -735,803 3,144,146 101,198,978
Receivable Turnover (TTM) 18.26 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.15 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -97.82 -0.15 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -123.49 1.79 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -127.78 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % 94.43 94.41 --
EPS (TTM) % -68.75 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Proteostasis Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 65.14%
# of Holders: 83
Total Shares Held: 23,904,081
3 Mo. Net Change: -575,988
# New Positions: 31
# Closed Positions: 15
# Increased Positions: 60
# Reduced Positions: 25
# Net Buyers: 35
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.